text
"['\n4. 매출 및 수주상황\n가. 매출실적\n\xa0 \xa0 \xa0 ( 단위 : 백만원 )\n구분\n사업부문\n품목\n구분\n제52기 반기\n제51 기\n제50 기\n계속영업사업\n산업설비공사\n산업설비플랜트E.P.C\n수출\n84\n1,181\n1,723\n내수\n57,699\n70,505\n70,098\n합계\n57,783\n71,686\n71,821\n화장품\n노보스트라타 등\n수출\n-\n-\n-\n내수\n12\n402\n649\n합계\n12\n402\n649\n건강식품\n스위치온 등\n수출\n-\n-\n-\n내수\n1,221\n1,253\n-\n합계\n1,221\n1,253\n-\n셀론텍\n리젠씰, 카티졸 등\n수출\n-\n-\n-\n내수\n6,352\n2,345\n-\n합계\n6,352\n2,345\n-\n기타\n젠바디 등\n수출\n-\n-\n-\n내수\n13\n39\n-\n합계\n13\n39\n-\n소계\n수출\n84\n1,181\n1,723\n내수\n65,297\n74,544\n70,747\n합계\n65,381\n75,725\n72,470\n중단영업사업\n세원이앤씨_PE\n열교환기,반응기 등\n수출\n-\n-\n42,401\n내수\n-\n-\n8,722\n합계\n-\n-\n51,123\n세원이앤씨_PL\nVALVE 등\n수출\n-\n-\n10\n내수\n-\n-\n2,713\n합계\n-\n-\n2,723\n세원이앤씨_RMS\n세포치료제,가족제대혈은행\n수출\n-\n-\n163\n내수\n-\n-\n12,216\n합계\n-\n-\n12,379\n상해세원액압유한공사\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n-\n179\n합계\n-\n-\n179\n셀론텍\n콘드론, 오스론,베이비셀\n수출\n-\n-\n내수\n302\n147\n합계\n302\n147\n소계\n수출\n-\n-\n42,574\n내수\n302\n147\n23,830\n합계\n302\n147\n66,404\n나. 수주상황\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n기초\n증감액\n공사수익인식\n기말\n산업설비공사\n103,360,562\n46,885,113\n(60,379,309)\n89,866,367\n다. 진행률 적용 수주 현황\n(단위: 천원)\n계약처\n계약일자\n계약상완성기한\n진행률\n수주총액\n계약자산\n매출채권\n총액\n손상차손누계액\n총액\n대손충당금\n머크버슘머트리얼즈코리아㈜\n20/12/02\n22/07/31\n100%\n7,835,000\n650,000\n-\n-\n-\n금호피앤비화학㈜\n21/03/23\n22/06/30\n100%\n7,680,000\n-\n-\n-\n-\n스미세이케미칼㈜\n21/04/01\n22/11/30\n98%\n16,630,050\n1,272,256\n-\n258,225\n-\n한화솔루션㈜\n21/04/06\n22/09/30\n75%\n32,720,069\n133,088\n-\n-\n-\n금호미쓰이화학㈜\n21/06/29\n22/12/31\n52%\n30,389,000\n-\n-\n2,006,950\n-\n티이엠씨 주식회사\n21/11/16\n22/07/31\n61%\n6,230,000\n-\n-\n-\n-\n금호석유화학(주)여수정밀화학\n21/12/17\n23/06/30\n17%\n22,440,000\n309,504\n-\n1,303,500\n-\n금호미쓰이화학㈜\n22/03/02\n22/08/31\n96%\n4,410,000\n-\n-\n485,100\n-\n에스케이트리켐 주식회사\n22/03/21\n23/02/15\n23%\n29,466,000\n-\n-\n3,239,500\n-\n에어리퀴드어드밴스드머티리얼즈\n22/06/07\n22/10/06\n7%\n6,260,000\n423,802\n-\n-\n-\n']"
